← Browse by Condition
Medical Condition
lupus nephritis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 3
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canad...
Sponsor
Cabaletta Bio
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Enrollment
462 pts
Location
United States, Argen...
Sponsor
Novartis Pharmaceuticals
NCT04702256 Phase 3
Recruiting
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Enrollment
196 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...